Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, randomised, double-blind, placebo-controlled, proof-of-mechanism and proof-of-concept study.
Nijjar JS, Abbott-Banner K, Alvarez Y, Aston N, Bass D, Bentley JH, Ellis J, Ellson C, Emery EC, Feeney M, Fernando D, Inman D, Kaur R, Modis LK, Munoz Vicente S, Muya C, Nistala K, Panoilia E, Ray R, Siederer S, Smith JE, Weir L, Wisniacki N.
Nijjar JS, et al. Among authors: bentley jh.
Ann Rheum Dis. 2024 Oct 17:ard-2023-225434. doi: 10.1136/ard-2023-225434. Online ahead of print.
Ann Rheum Dis. 2024.
PMID: 39419538
Free article.